These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15356071)

  • 1. Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone.
    Honisett SY; Stojanovska L; Sudhir K; Kingwell BA; Dawood T; Komesaroff PA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4615-9. PubMed ID: 15356071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
    Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
    Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rosiglitazone on the cardiovascular profile in postmenopausal women without diabetes mellitus: interplay of thiazolidinediones and hormone therapy.
    Chen IC; Lee WH; Chao TH; Li YH; Tsai WC; Pan HA; Tseng SY; Chen JY
    Menopause; 2012 Jul; 19(7):812-9. PubMed ID: 22415569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
    Casanova G; Radavelli S; Lhullier F; Spritzer PM
    Fertil Steril; 2009 Aug; 92(2):605-12. PubMed ID: 18706557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
    Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.
    Kovacic JC; Martin A; Carey D; Wand H; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr A;
    Antivir Ther; 2005; 10(1):135-43. PubMed ID: 15751771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
    Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease.
    Blümel JE; Castelo-Branco C; Leal T; Gallardo L; Saini J; Ferron S; Haya J
    Climacteric; 2003 Mar; 6(1):38-44. PubMed ID: 12725663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Esposito K; Ciotola M; Carleo D; Schisano B; Saccomanno F; Sasso FC; Cozzolino D; Assaloni R; Merante D; Ceriello A; Giugliano D
    Diabetes Care; 2006 May; 29(5):1071-6. PubMed ID: 16644639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women--a randomised controlled trial.
    Scarabin PY; Alhenc-Gelas M; Oger E; Plu-Bureau G
    Thromb Haemost; 1999 May; 81(5):673-5. PubMed ID: 10365734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens.
    Pérez-López FR; Cuadros-López JL; Fernández-Alonso AM; Cuadros-Celorrio AM; Sabatel-López RM; Chedraui P
    Gynecol Endocrinol; 2010 Jul; 26(7):533-8. PubMed ID: 19916873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
    Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I
    Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
    Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.
    Gordon JL; Rubinow DR; Watkins L; Hinderliter AL; Caughey MC; Girdler SS
    J Clin Endocrinol Metab; 2020 May; 105(5):e2050-60. PubMed ID: 31838497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
    Thunell L; Andersson B; Glassell M; Mattsson LA
    Maturitas; 2006 Mar; 53(4):430-8. PubMed ID: 16198072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.